Cargando…
Correction: Davidi et al. Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo. Cancers 2022, 14, 2959
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954138/ https://www.ncbi.nlm.nih.gov/pubmed/36831698 http://dx.doi.org/10.3390/cancers15041182 |
| _version_ | 1784894052737482752 |
|---|---|
| author | Davidi, Shiri Jacobovitch, Sara Shteingauz, Anna Martinez-Conde, Antonia Braten, Ori Tempel-Brami, Catherine Zeevi, Einav Frechtel-Gerzi, Roni Ene, Hila Dor-On, Eyal Voloshin, Tali Tzchori, Itai Haber, Adi Giladi, Moshe Kinzel, Adrian Weinberg, Uri Palti, Yoram |
| author_facet | Davidi, Shiri Jacobovitch, Sara Shteingauz, Anna Martinez-Conde, Antonia Braten, Ori Tempel-Brami, Catherine Zeevi, Einav Frechtel-Gerzi, Roni Ene, Hila Dor-On, Eyal Voloshin, Tali Tzchori, Itai Haber, Adi Giladi, Moshe Kinzel, Adrian Weinberg, Uri Palti, Yoram |
| author_sort | Davidi, Shiri |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9954138 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99541382023-02-25 Correction: Davidi et al. Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo. Cancers 2022, 14, 2959 Davidi, Shiri Jacobovitch, Sara Shteingauz, Anna Martinez-Conde, Antonia Braten, Ori Tempel-Brami, Catherine Zeevi, Einav Frechtel-Gerzi, Roni Ene, Hila Dor-On, Eyal Voloshin, Tali Tzchori, Itai Haber, Adi Giladi, Moshe Kinzel, Adrian Weinberg, Uri Palti, Yoram Cancers (Basel) Correction MDPI 2023-02-13 /pmc/articles/PMC9954138/ /pubmed/36831698 http://dx.doi.org/10.3390/cancers15041182 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Correction Davidi, Shiri Jacobovitch, Sara Shteingauz, Anna Martinez-Conde, Antonia Braten, Ori Tempel-Brami, Catherine Zeevi, Einav Frechtel-Gerzi, Roni Ene, Hila Dor-On, Eyal Voloshin, Tali Tzchori, Itai Haber, Adi Giladi, Moshe Kinzel, Adrian Weinberg, Uri Palti, Yoram Correction: Davidi et al. Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo. Cancers 2022, 14, 2959 |
| title | Correction: Davidi et al. Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo. Cancers 2022, 14, 2959 |
| title_full | Correction: Davidi et al. Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo. Cancers 2022, 14, 2959 |
| title_fullStr | Correction: Davidi et al. Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo. Cancers 2022, 14, 2959 |
| title_full_unstemmed | Correction: Davidi et al. Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo. Cancers 2022, 14, 2959 |
| title_short | Correction: Davidi et al. Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo. Cancers 2022, 14, 2959 |
| title_sort | correction: davidi et al. tumor treating fields (ttfields) concomitant with sorafenib inhibit hepatocellular carcinoma in vitro and in vivo. cancers 2022, 14, 2959 |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954138/ https://www.ncbi.nlm.nih.gov/pubmed/36831698 http://dx.doi.org/10.3390/cancers15041182 |
| work_keys_str_mv | AT davidishiri correctiondavidietaltumortreatingfieldsttfieldsconcomitantwithsorafenibinhibithepatocellularcarcinomainvitroandinvivocancers2022142959 AT jacobovitchsara correctiondavidietaltumortreatingfieldsttfieldsconcomitantwithsorafenibinhibithepatocellularcarcinomainvitroandinvivocancers2022142959 AT shteingauzanna correctiondavidietaltumortreatingfieldsttfieldsconcomitantwithsorafenibinhibithepatocellularcarcinomainvitroandinvivocancers2022142959 AT martinezcondeantonia correctiondavidietaltumortreatingfieldsttfieldsconcomitantwithsorafenibinhibithepatocellularcarcinomainvitroandinvivocancers2022142959 AT bratenori correctiondavidietaltumortreatingfieldsttfieldsconcomitantwithsorafenibinhibithepatocellularcarcinomainvitroandinvivocancers2022142959 AT tempelbramicatherine correctiondavidietaltumortreatingfieldsttfieldsconcomitantwithsorafenibinhibithepatocellularcarcinomainvitroandinvivocancers2022142959 AT zeevieinav correctiondavidietaltumortreatingfieldsttfieldsconcomitantwithsorafenibinhibithepatocellularcarcinomainvitroandinvivocancers2022142959 AT frechtelgerzironi correctiondavidietaltumortreatingfieldsttfieldsconcomitantwithsorafenibinhibithepatocellularcarcinomainvitroandinvivocancers2022142959 AT enehila correctiondavidietaltumortreatingfieldsttfieldsconcomitantwithsorafenibinhibithepatocellularcarcinomainvitroandinvivocancers2022142959 AT doroneyal correctiondavidietaltumortreatingfieldsttfieldsconcomitantwithsorafenibinhibithepatocellularcarcinomainvitroandinvivocancers2022142959 AT voloshintali correctiondavidietaltumortreatingfieldsttfieldsconcomitantwithsorafenibinhibithepatocellularcarcinomainvitroandinvivocancers2022142959 AT tzchoriitai correctiondavidietaltumortreatingfieldsttfieldsconcomitantwithsorafenibinhibithepatocellularcarcinomainvitroandinvivocancers2022142959 AT haberadi correctiondavidietaltumortreatingfieldsttfieldsconcomitantwithsorafenibinhibithepatocellularcarcinomainvitroandinvivocancers2022142959 AT giladimoshe correctiondavidietaltumortreatingfieldsttfieldsconcomitantwithsorafenibinhibithepatocellularcarcinomainvitroandinvivocancers2022142959 AT kinzeladrian correctiondavidietaltumortreatingfieldsttfieldsconcomitantwithsorafenibinhibithepatocellularcarcinomainvitroandinvivocancers2022142959 AT weinberguri correctiondavidietaltumortreatingfieldsttfieldsconcomitantwithsorafenibinhibithepatocellularcarcinomainvitroandinvivocancers2022142959 AT paltiyoram correctiondavidietaltumortreatingfieldsttfieldsconcomitantwithsorafenibinhibithepatocellularcarcinomainvitroandinvivocancers2022142959 |